All
The price of gold: Investment vehicle appealing, yet risky
August 1st 2009For thousands of years, gold has been viewed by many as the ultimate safe haven for investors, especially in times of economic distress. If these gut-wrenching times have you thinking about investing in gold as a guiding hand through the fiscal wilderness, you're not alone. Recent spikes in the price of gold reflect the usual emotional attachment to that commodity in times of economic gloom.
Risky business: Performing treatments not approved for use in U.S. jeopardizes medical license
August 1st 2009Dr. Fat has always prided himself on providing his patients with leading dermatologic treatments. He is an avid reader of medical journals, and he attends dermatology meetings both in the United States and abroad to learn about the latest in both medical and cosmetic procedures.
Face to Face: Surgeon’s memoir details historic transplant
June 10th 2009Cleveland - Cleveland Clinic surgeon Maria Siemionow, M.D., Ph.D., who led a team of doctors who performed the first near-total face transplant in the United States in late 2008, has written a book about the ground-breaking procedure.
ALA, PDT team up: Combination laser therapy proves effective for treatment of acne
June 1st 2009A novel treatment approach using ALA-PDT in combination with standard topical therapies proves to be very effective in treating mild-to-severe acne lesions. According to one expert, this combination approach can achieve a high clearance of acne lesions and may be a solution for treating acne lesions long term.
Acne treatments: New options tackle clinical, compliance challenges
June 1st 2009Most of the significant recent advances in acne treatment involve changes in vehicle formulation that may improve medications' tolerability, efficacy or both, a leading clinician and researcher says. For treating tough acne cases, another expert adds, dermatologists must use simpler, more patient-friendly regimens.
The next 'big thing': Nanotechnology enters skincare realm
May 1st 2009The concept of nanotechnology, which relies on nano-sized synthetic materials to provide the functionality of automated machines, is nothing new. However, the science of small has moved from electronics into the biological realm. Balancing the benefits and risks of nanotechnology with respect to patient treatment is essential, an expert says.
Blocking out rays: Once-a-day topical serum protects skin
May 1st 2009The orthodox use of strong sunscreens is largely effective in blocking harmful ultraviolet (UV) rays. However, this protective measure is not 100 percent successful. Recent research finds that the once-a-day application of a novel topical serum containing antioxidants not only helps protect the skin from harmful UV rays, it also improves the visible signs of photodamage.
Antiangiogenesis agents: Therapy shows promise in treating port wine stains and cutaneous disease
May 1st 2009Physicians historically have used antiangiogenic agents in oncologic and ophthalmologic indications, but dermatologic applications for these medications are under investigation, an expert says.
Lentigo maligna: Topical agent option for malignant melanoma
May 1st 2009Preliminary, yet promising, outcomes in two patients suggests dual therapy involving limited surgical excision followed by topical application of imiquimod 5 percent cream (Aldara, Graceway) may be an option to consider for treating invasive malignant melanoma surrounded by lentigo maligna (LM) in patients who refuse or are not good candidates for more extensive surgery, according to researchers from the department of dermatology, Saint Louis University School of Medicine, St. Louis.
Legislative: 'Bonanza of dollars': Stimulus package expected to benefit skin disease research
May 1st 2009As a result of the American Recovery and Reinvestment Act (ARRA) - the "stimulus package" - a bonanza of new research money is now available at the National Institutes of Health (NIH), and skin disease research is in a position to benefit.
Internal buyouts: Plan well; sell your medical practice for millions at retirement
May 1st 2009As attorneys and consultants to thousands of physicians across the country, we are constantly astounded by the attitudes of physicians regarding the sale of their medical practices. Most often, today, we hear the complaint that doctors do not feel they can sell a practice for any significant value. They generally do not feel the practice is "worth anything," especially if they do not have younger partners to buy them out.
Reducing risks: Systemic retinoids useful for nonmelanoma skin cancer
May 1st 2009Systemic retinoids can be used to help transplant patients, long-term phototherapy patients, and patients with cutaneous T-cell lymphoma fight skin cancer. Systemic retinoids are also used in psoriasis patients with long-term exposure to phototherapy.